Table of Content
1. Global Nerve Repair and Regeneration Market – Executive Summary
1.1. Global Market Overview
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Fact.MR Analysis and Recommendations
2. Global Nerve Repair and Regeneration Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Introduction and Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Nerve Repair and Regeneration
3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices
3.1.3. COVID-19 Impact Benchmark with Previous Crisis
3.1.3.1. Change in Nerve Repair and Regeneration Demand
3.1.3.2. Before and After COVID-19 Crisis (Projected)
3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)
3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)
3.1.4. Impact on Market and Value (US$ Mn)
3.1.4.1. Likely Loss of Value in 2020
3.1.4.2. Mid-term and Long Term Forecast
3.1.4.3. Quarter by Quarter Demand and Recovery Assessment
3.1.5. Anticipated Demand and Value Recovery Curve
3.1.5.1. Likelihood of U-Shape Recovery
3.1.5.2. Likelihood of L-Shape Recovery
3.1.6. Recovery Period Assessment by Key Countries
3.1.7. Recovery Assessment by Key Market Segments
3.1.8. Action Points and Recommendations for Suppliers
3.1.9. Impact on Trade Balance
3.2. Key Trends Impacting the Market
3.3. Formulation and Source Development Trends
4. Market Background and foundation Data Points
4.1. Need of the Hour for Industries
4.2. Industry Wise Industry 4.0
4.3. Nerve Repair and Regeneration – Strategic Priorities
4.4. Life Cycle Stage
4.5. Importance of Technology
4.6. Use Cases of Nerve Repair and Regeneration
4.7. Forecast Factors: Relevance and Impact
4.8. Investment Feasibility Matrix
4.9. PESTLE Analysis
4.10. Porter’s Five Forces Analysis
4.11. Market Dynamics
4.11.1. Drivers
4.11.2. Restraints
4.11.3. Opportunity Analysis
4.11.4. Trend
5. Global Nerve Repair and Regeneration Market Demand (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2026
5.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2026
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Value (US$ Mn) Analysis By Application, 2017-2021
6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2022-2026
6.3.1. Neurostimulation & Neuromodulation Surgeries
6.3.2. Neurorrhaphy
6.3.3. Nerve Grafting
6.3.4. Stem Cell Therapy
6.4. Market Attractiveness Analysis By Application
7. Global Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026, by Product
7.1. Introduction / Key Findings
7.2. Historical Market Value (US$ Mn) Analysis By Product , 2017-2021
7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2022-2026
7.3.1. Neurostimulation & Neuromodulation Devices
7.3.2. Biomaterials
7.4. Market Attractiveness Analysis By Product
8. Global Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026, by End User
8.1. Introduction / Key Findings
8.2. Historical Market Value (US$ Mn) Analysis By End User, 2017-2021
8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2022-2026
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Ambulatory Surgery Centers
8.4. Market Attractiveness Analysis By End User
9. Global Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026, by Region
9.1. Introduction / Key Findings
9.2. Historical Market Value (US$ Mn) Analysis By Region, 2017-2021
9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia & Oceania
9.3.6. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2026
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Application
10.3.3. By Product
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Application
10.4.3. By Product
11. Latin America Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Rest of Latin America
11.3.2. By Application
11.3.3. By Product
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Application
11.4.3. By Product
11.4.4. By End User
12. Europe Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. France
12.3.1.3. Italy
12.3.1.4. Spain
12.3.1.5. UK
12.3.1.6. BENELUX
12.3.1.7. Russia
12.3.1.8. Rest of Europe
12.3.2. By Application
12.3.3. By Product
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Application
12.4.3. By Product
12.4.4. By End User
13. East Asia Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
13.3.1. By Country
13.3.1.1. China
13.3.1.2. Japan
13.3.1.3. South Korea
13.3.2. By Application
13.3.3. By Product
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Application
13.4.3. By Product
13.4.4. By End User
14. South Asia & Oceania Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Malaysia
14.3.1.4. Singapore
14.3.1.5. Vietnam
14.3.1.6. ANZ
14.3.1.7. Rest of South Asia & Oceania
14.3.2. By Application
14.3.3. By Product
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Application
14.4.3. By Product
14.4.4. By End User
15. Middle East and Africa Nerve Repair and Regeneration Market Analysis 2017-2021 and Forecast 2022-2026
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
15.3.1. By Country
15.3.1.1. GCC Countries
15.3.1.2. South Africa
15.3.1.3. Israel
15.3.1.4. Rest of Middle East and Africa (MEA)
15.3.2. By Application
15.3.3. By Product
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Application
15.4.3. By Product
15.4.4. By End User
16. Market Structure Analysis
16.1. Market Analysis by Tier of Companies
16.2. Market Concentration
16.3. Market Share Analysis of Top Players
16.4. Market Presence Analysis
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Competition Deep Dive
17.3.1. Baxter
17.3.1.1. Company Overview
17.3.1.2. Source overview
17.3.1.3. SWOT Analysis
17.3.1.4. Key Developments
17.3.2. Polyganics B.V.
17.3.2.1. Company Overview
17.3.2.2. Source overview
17.3.2.3. SWOT Analysis
17.3.2.4. Key Developments
17.3.3. Nevro
17.3.3.1. Company Overview
17.3.3.2. Source overview
17.3.3.3. SWOT Analysis
17.3.3.4. Key Developments
17.3.4. Stryker
17.3.4.1. Company Overview
17.3.4.2. Source overview
17.3.4.3. SWOT Analysis
17.3.4.4. Key Developments
17.3.5. Abbott Laboratories
17.3.5.1. Company Overview
17.3.5.2. Source overview
17.3.5.3. SWOT Analysis
17.3.5.4. Key Developments
17.3.6. AxoGen, Inc.
17.3.6.1. Company Overview
17.3.6.2. Source overview
17.3.6.3. SWOT Analysis
17.3.6.4. Key Developments
17.3.7. Boston Scientific Corporation
17.3.7.1. Company Overview
17.3.7.2. Source overview
17.3.7.3. SWOT Analysis
17.3.7.4. Key Developments
17.3.8. Integra LifeSciences Corporation
17.3.8.1. Company Overview
17.3.8.2. Source overview
17.3.8.3. SWOT Analysis
17.3.8.4. Key Developments
17.3.9. LivaNova, PLC
17.3.9.1. Company Overview
17.3.9.2. Source overview
17.3.9.3. SWOT Analysis
17.3.9.4. Key Developments
17.3.10. Medtronic plc
17.3.10.1. Company Overview
17.3.10.2. Source overview
17.3.10.3. SWOT Analysis
17.3.10.4. Key Developments
17.3.11. NeuroPace, Inc.
17.3.11.1. Company Overview
17.3.11.2. Source overview
17.3.11.3. SWOT Analysis
17.3.11.4. Key Developments
17.3.12. Synapse Biomedical Inc.
17.3.12.1. Company Overview
17.3.12.2. Source overview
17.3.12.3. SWOT Analysis
17.3.12.4. Key Developments
17.3.13. Synovis Micro Companies Alliance, Inc.
17.3.13.1. Company Overview
17.3.13.2. Source overview
17.3.13.3. SWOT Analysis
17.3.13.4. Key Developments
18. Assumptions And Acronyms Used
19. Research Methodology